Sommaire

• • ·Table of Contents

    Page :A1

    
• • ·Editorial Board

    Page :A4

    
• • ·Information for Readers

    Page :A5

    
• • ·Correction

    Page :281

    

• Trial Design

  • ·TRIple pill vs Usual care Management for Patients with mild-to-moderate Hypertension (TRIUMPH): Study protocol

    Page :127-132

    Abdul Salam, Ruth Webster, Kavita Singh, Sudha Kallakuri, Anthony Rodgers, Dorairaj Prabhakaran, Pallab K. Maulik, Stephen Jan, Simon Thom, Nitish Naik, Rama Guggilla, Vanessa Selak, Anushka Patel

    Résumé Résumé Plan Plan  
  • ·Amsterdam Investigator–initiateD Absorb strategy all-comers trial (AIDA trial): A clinical evaluation comparing the efficacy and performance of ABSORB everolimus-eluting bioresorbable vascular scaffold strategy vs the XIENCE family (XIENCE PRIME or XIENCE Xpedition) everolimus-eluting coronary stent strategy in the treatment of coronary lesions in consecutive all-comers: Rationale and study design

    Page :133-140

    Pier Woudstra, Maik J. Grundeken, Robin P. Kraak, Mariëlla E.C.J. Hassell, E. Karin Arkenbout, Jan Baan, Marije M. Vis, Karel T. Koch, Jan G.P. Tijssen, Jan J. Piek, Robbert J. de Winter, José P.S. Henriques, Joanna J. Wykrzykowska

    Résumé Résumé Plan Plan  
  • ·Effect of A Reduction in glomerular filtration rate after NEphrectomy on arterial STiffness and central hemodynamics: Rationale and design of the EARNEST study

    Page :141

    William E. Moody, Laurie A. Tomlinson, Charles J. Ferro, Richard P. Steeds, Patrick B. Mark, Daniel Zehnder, Charles R. Tomson, John R. Cockcroft, Ian B. Wilkinson, Jonathan N. Townend

    Résumé Résumé Plan Plan  

• Cardiac Safety Research Consortium

  • ·Comparison of automated measurements of electrocardiographic intervals and durations by computer-based algorithms of digital electrocardiographs

    Page :150

    Paul Kligfield, Fabio Badilini, Ian Rowlandson, Joel Xue, Elaine Clark, Brian Devine, Peter Macfarlane, Johan de Bie, David Mortara, Saeed Babaeizadeh, Richard Gregg, Eric D. Helfenbein, Cynthia L. Green

    Résumé Résumé Plan Plan  

• Clinical Investigations

  • ·Association of all-cause and cardiovascular mortality with prehypertension: A meta-analysis

    Page :160

    Yuli Huang, Liang Su, Xiaoyan Cai, Weiyi Mai, Sheng Wang, Yunzhao Hu, Yanxian Wu, Hongfeng Tang, Dingli Xu

    Résumé Résumé Plan Plan  
  • ·Arm exercise as an alternative to pharmacologic stress testing: Arm exercise stress testing and outcome

    Page :169-177

    Wade H. Martin, Hong Xian, Daniel Wagner, Pooja Chandiramani, Emily Bainter, Nasreen Ilias-Khan

    Résumé Résumé Plan Plan  
  • ·Erectile dysfunction in the cardiology practice—a patients' perspective

    Page :178-185

    Melianthe P.J. Nicolai, Joyce van Bavel, G. Aernout Somsen, Greetje J. de Grooth, Igor I. Tulevski, Anouk Lorsheyd, Hein Putter, Martin J. Schalij, Rob C.M. Pelger, Henk W. Elzevier

    Résumé Résumé Plan Plan  
  • ·Growth differentiation factor 15 and cardiovascular events in patients with stable ischemic heart disease (The Heart and Soul Study)

    Page :186

    David W. Schopfer, Ivy A. Ku, Mathilda Regan, Mary A. Whooley

    Résumé Résumé Plan Plan  
  • ·The effects of exercise on cardiovascular biomarkers in patients with chronic heart failure

    Page :193

    Tariq Ahmad, Mona Fiuzat, Daniel B. Mark, Ben Neely, Megan Neely, William E. Kraus, Dalane W. Kitzman, David J. Whellan, Mark Donahue, Faiez Zannad, Ileana L. Piña, Kirkwood Adams, Christopher M. O'Connor, G. Michael Felker

    Résumé Résumé Plan Plan  
  • ·Absolute survival after cardiac resynchronization therapy according to baseline QRS duration: A multinational 10-year experience : Data from the Multicenter International CRT Study

    Page :203

    Maurizio Gasparini, Christophe Leclercq, Cheuk-Man Yu, Angelo Auricchio, Jonathan S. Steinberg, Barbara Lamp, Catherine Klersy, Francisco Leyva

    Résumé Résumé Plan Plan  
  • ·EPITOME-2: An open-label study assessing the transition to a new formulation of intravenous epoprostenol in patients with pulmonary arterial hypertension

    Page :210-217

    Olivier Sitbon, Marion Delcroix, Emmanuel Bergot, Anco B. Boonstra, John Granton, David Langleben, Pilar Escribano Subías, Nazzareno Galiè, Thomas Pfister, Jean-Christophe Lemarié, Gérald Simonneau

    Résumé Résumé Plan Plan  
  • ·Two formulations of epoprostenol sodium in the treatment of pulmonary arterial hypertension: EPITOME-1 (epoprostenol for injection in pulmonary arterial hypertension), a phase IV, open-label, randomized study

    Page :218

    Kelly M. Chin, David B. Badesch, Ivan M. Robbins, Victor F. Tapson, Harold I. Palevsky, Nick H. Kim, Steven M. Kawut, Adaani Frost, Wade W. Benton, Jean-Christophe Lemarie, Frederic Bodin, Lewis J. Rubin, Vallerie McLaughlin

    Résumé Résumé Plan Plan  
  • ·Short-term hemodynamic effect of angiotensin-converting enzyme inhibition in patients with severe aortic stenosis : A placebo-controlled, randomized study

    Page :226-234

    Morten Dalsgaard, Kasper Iversen, Jesper Kjaergaard, Peer Grande, Jens Peter Goetze, Peter Clemmensen, Christian Hassager

    Résumé Résumé Plan Plan  
  • ·Balloon aortic valvuloplasty in the era of transcatheter aortic valve replacement: Acute and long-term outcomes

    Page :235-240

    Hélène Eltchaninoff, Eric Durand, Bogdan Borz, Akira Furuta, Karim Bejar, Alexandre Canville, Ali Farhat, Chiara Fraccaro, Matthieu Godin, Christophe Tron, Rahul Sakhuja, Alain Cribier

    Résumé Résumé Plan Plan  
  • ·Multicenter randomized trial of 3-month cilostazol use in addition to dual antiplatelet therapy after biolimus-eluting stent implantation for long or multivessel coronary artery disease

    Page :241

    Young Jin Youn, Jun-Won Lee, Sung Gyun Ahn, Seung-Hwan Lee, Hyunmin Choi, Cheol Woong Yu, Young Joon Hong, Hyuck Moon Kwon, Myeong-Ki Hong, Yangsoo Jang, Junghan Yoon

    Résumé Résumé Plan Plan  
  • ·A survey of the 3-decade outcome for patients with giant aneurysms caused by Kawasaki disease

    Page :249-258

    Etsuko Tsuda, Kenji Hamaoka, Hiroyuki Suzuki, Hisanori Sakazaki, Yosuke Murakami, Masao Nakagawa, Hisashi Takasugi, Muneo Yoshibayashi

    Résumé Résumé Plan Plan  
  • ·Patterns and prognosis of all components of the J-wave pattern in multiethnic athletes and ambulatory patients

    Page :259-266

    David Muramoto, Celina M. Yong, Nikhil Singh, Sonya Aggarwal, Marco Perez, Euan Ashley, David Hadley, Victor Froelicher

    Résumé Résumé Plan Plan  
  • ·Influence of heart failure symptoms and ejection fraction on short- and long-term outcomes for older patients with non–ST-segment elevation myocardial infarction

    Page :267

    Sean van Diepen, Anita Y. Chen, Tracy Y. Wang, Karen P. Alexander, Justin A. Ezekowitz, Eric D. Peterson, Matthew T. Roe

    Résumé Résumé Plan Plan  
  • ·Genetic diversity of the KCNE1 gene and susceptibility to postoperative atrial fibrillation

    Page :274

    Konstantinos V. Voudris, Stavros Apostolakis, Panagiotis Karyofillis, Konstantinos Doukas, Apostolos Zaravinos, Vasilis P. Androutsopoulos, Alkis Michalis, Vassilis Voudris, Demetrios A. Spandidos

    Résumé Résumé Plan Plan  

• Letters to the Editor

  • ·Use of preoperative cardiac troponin T to identify patients at risk for acute myocardial infarction and long-term mortality after major noncardiac surgery

    Page :e5

    Fu Shan Xue, Yi Cheng, Rui Ping Li

    
  • ·Letter in response to “Use of preoperative cardiac troponin T to identify patients at risk for acute myocardial infraction and long-term mortality after major noncardiac surgery”

    Page :e7

    Peter Nagele, Frank Brown, Brian F. Gage, David W. Gibson, J. Philip Miller, Allan S. Jaffe, Fred S. Apple, Mitchell G. Scott